Transaction DateRecipientSharesTypePriceValue
16th November 2020Daniel H. Orenstein5,000Exercise of derivative$10.34$51,700.00
16th November 2020Daniel H. Orenstein5,000Open or private sale$33.93$169,666.00
14th November 2020Timothy G. Ferris2,033Open or private sale$34.45$70,038.88
14th November 2020Timothy G. Ferris2,333Exercise of derivative$11.78$27,482.74
13th November 2020Timothy G. Ferris300Open or private sale$35.52$10,655.01
2nd November 2020Linda Llewelyn2,042Open or private sale$33.63$68,671.03
2nd November 2020Paul Horstmeier9,749Open or private sale$33.63$327,858.87
2nd November 2020Paul Horstmeier10,750Exercise of derivative$15.84$170,280.00
2nd November 2020Linda Llewelyn200Open or private sale$34.37$6,874.00
2nd November 2020Linda Llewelyn2,242Exercise of derivative$10.80$24,213.60
Health Catalyst
Health Catalyst logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 3/10.

Health Catalyst, Inc. provides healthcare data warehousing and process improvement solutions. Its solutions include accountable care, analytics adoption model, care management solutions, healthcare analytics, late-binding data warehouse, population health management, and predictive analytics. The company operates through two segments: Technology and Professional Services.

Ticker: HCAT
Sector: Technology Services
Industry: Packaged Software
SEC Central Index Key (CIK): 1636422
Employees: 900
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags
Cash at Carrying Value: $104 M (477%)
Assets, Current: $397 M (50%)
Property, Plant and Equipment, Net: $4 M (0%)
Other Assets, Noncurrent: $2 M (188%)
Assets: $466 M (54%)
Accounts Payable, Current: $2 M (-33%)
Liabilities, Current: $50 M (4%)
Long-term Debt, Excluding Current Maturities: $163 M (239%)
Other Liabilities, Noncurrent: $1 M (275%)
Liabilities: $232 M (128%)
Common Stock, Value, Issued: $39 Th (5%)
Common Stock, Shares, Issued: $39 M (5%)
Retained Earnings (Accumulated Deficit): $655 M (7%)
Accumulated Other Comprehensive Income (Loss), Net of Tax: $175 Th (143%)
Stockholders' Equity (Parent): $234 M (0%)
Liabilities and Equity: $466 M (54%)
Revenue: $43 M (0%)
Research and Development: $12 M (-52%)
Sales and Marketing: $13 M (-51%)
General and Administrative Expenses: $8 M (-54%)
Operating Income/Loss: $16 M (-53%)
Provision for income taxes: $4 Th (-99%)